Literature DB >> 2784865

Circulating IgA- and IgM-rheumatoid factors in patients with primary Sjögren syndrome. Correlation to extraglandular manifestations.

K Müller1, P Oxholm, M Mier-Madsen, A Wiik.   

Abstract

IgM- and IgA-rheumatoid factors (RF) were determined by ELISA technique in 40 consecutive patients with primary Sjögren syndrome (primary SS), all fulfilling the Copenhagen diagnostic criteria. Increased concentrations of IgM-RF were found in 25 patients (63%) (median concentration: 85 IU/ml, range 11-302 IU/ml). Increased concentrations of IgA-RF were found in 22 of the patients (55%) (median concentration: 100 AU/ml, range 25-255 AU/ml). The levels of IgM- and IgA-RF were closely correlated (r = 0.82, p less than 0.001). IgM-RF (p = 0.037), but not IgA-RF (p = 0.17), was significantly correlated to the presence of antinuclear antibodies (ANA). In contrast, IgA-RF (p = 0.002), but not IgM RF (p = 0.068), was significantly correlated to the presence of hypergammaglobulinemia. The most common extraglandular manifestations were: arthralgia/synovitis (60%), myalgia/myositis (28%), Raynaud's phenomenon (20%) and pulmonary manifestations (15%). Concentrations of both IgM-RF (r = 0.43, p less than 0.01) and IgA-RF (r = 0.57, p less than 0.001) were correlated to the number of extraglandular manifestations present in each patient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784865     DOI: 10.3109/03009748909095400

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  6 in total

1.  Active immunological profile is associated with systemic Sjögren's syndrome.

Authors:  Clothilde Martel; Guillaume Gondran; David Launay; Fabrice Lalloué; Sylvain Palat; Marc Lambert; Kim Ly; Veronique Loustaud-Ratti; Holly Bezanahary; Eric Hachulla; Marie Odile Jauberteau; Elisabeth Vidal; Pierre Yves Hatron; Anne Laure Fauchais
Journal:  J Clin Immunol       Date:  2011-07-09       Impact factor: 8.317

2.  Monoclonal process in primary Sjögren's syndrome and cross-reactive idiotype associated with rheumatoid factor.

Authors:  P D Katsikis; P Y Youinou; V Galanopoulou; N M Papadopoulos; A G Tzioufas; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjögren's syndrome.

Authors:  E Borda; J J Camusso; C Perez Leiros; S Bacman; O Hubscher; R Arana; L Sterin-Borda
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

4.  B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome.

Authors:  Wenzhao Meng; Yongmei Li; Emily Xue; Minoru Satoh; Ammon B Peck; Philip L Cohen; Robert A Eisenberg; Eline T Luning Prak
Journal:  J Clin Immunol       Date:  2012-02-17       Impact factor: 8.317

5.  IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren's syndrome.

Authors:  Maria Maślińska; Małgorzata Mańczak; Brygida Kwiatkowska; Vince Ramsperger; Long Shen; Lakshmanan Suresh
Journal:  Rheumatol Int       Date:  2021-01-26       Impact factor: 2.631

6.  Matrix metalloproteinases in recurrent corneal melting associated with primary Sjörgen's syndrome.

Authors:  Kristyna Brejchova; Petra Liskova; Enkela Hrdlickova; Martin Filipec; Katerina Jirsova
Journal:  Mol Vis       Date:  2009-11-14       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.